Alfonso Segarra

493 total citations
11 papers, 201 citations indexed

About

Alfonso Segarra is a scholar working on Nephrology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Alfonso Segarra has authored 11 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 3 papers in Surgery and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Alfonso Segarra's work include Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Acute Kidney Injury Research (2 papers). Alfonso Segarra is often cited by papers focused on Chronic Kidney Disease and Diabetes (4 papers), Renal Diseases and Glomerulopathies (4 papers) and Acute Kidney Injury Research (2 papers). Alfonso Segarra collaborates with scholars based in Spain and United States. Alfonso Segarra's co-authors include Natàlia Ramos, Manuel Praga, Jesús Egido, Ester González, R. Delgado, Gema Fernández‐Fresnedo, Irina B. Torres, Montserrat López, Maite Quiles and Irene Agraz and has published in prestigious journals such as Life Sciences, Clinical Journal of the American Society of Nephrology and Journal of Computer Assisted Tomography.

In The Last Decade

Alfonso Segarra

10 papers receiving 195 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfonso Segarra Spain 6 149 59 52 28 24 11 201
Juhani Myllymäki Finland 5 254 1.7× 82 1.4× 32 0.6× 60 2.1× 15 0.6× 7 284
Francesca Calero Spain 9 70 0.5× 32 0.5× 43 0.8× 26 0.9× 10 0.4× 17 170
Н А Мухин Russia 7 83 0.6× 17 0.3× 89 1.7× 33 1.2× 33 1.4× 53 221
Eleonora Moscaritolo Italy 5 198 1.3× 62 1.1× 61 1.2× 26 0.9× 14 0.6× 6 289
Tarun Kumar Saha Bangladesh 3 235 1.6× 86 1.5× 105 2.0× 11 0.4× 22 0.9× 4 253
Sarah Seiler-Mußler Germany 10 99 0.7× 20 0.3× 42 0.8× 9 0.3× 22 0.9× 13 212
Maarten A. de Jong Netherlands 9 181 1.2× 53 0.9× 34 0.7× 6 0.2× 31 1.3× 11 287
Aruna Dharmasena United Kingdom 8 60 0.4× 30 0.5× 19 0.4× 12 0.4× 16 0.7× 28 249
Silje Rafaelsen Norway 4 221 1.5× 22 0.4× 60 1.2× 89 3.2× 14 0.6× 5 296
Krzysztof Kiryluk United States 3 171 1.1× 48 0.8× 19 0.4× 11 0.4× 10 0.4× 10 209

Countries citing papers authored by Alfonso Segarra

Since Specialization
Citations

This map shows the geographic impact of Alfonso Segarra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfonso Segarra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfonso Segarra more than expected).

Fields of papers citing papers by Alfonso Segarra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfonso Segarra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfonso Segarra. The network helps show where Alfonso Segarra may publish in the future.

Co-authorship network of co-authors of Alfonso Segarra

This figure shows the co-authorship network connecting the top 25 collaborators of Alfonso Segarra. A scholar is included among the top collaborators of Alfonso Segarra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfonso Segarra. Alfonso Segarra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Goicoechea, Marián, Vicente Álvarez, Alfonso Segarra, et al.. (2021). Perfil clínico de los pacientes tratados con evolocumab en unidades hospitalarias de nefrología en España (RETOSS-NEFRO). Nefrología. 42(3). 301–310.
4.
Cases, Aleix, José Pórtoles, Jordi Calls, et al.. (2014). Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study. International Urology and Nephrology. 46(10). 1983–1995. 2 indexed citations
6.
Segarra, Alfonso, et al.. (2011). Assessing Glomerular Filtration Rate in Hospitalized Patients. Clinical Journal of the American Society of Nephrology. 6(10). 2411–2420. 41 indexed citations
7.
Fernández‐Fresnedo, Gema, Alfonso Segarra, Ester González, et al.. (2009). Rituximab Treatment of Adult Patients with Steroid-Resistant Focal Segmental Glomerulosclerosis. Clinical Journal of the American Society of Nephrology. 4(8). 1317–1323. 93 indexed citations
8.
Tovar, José L., Marı́a Buti, Alfonso Segarra, Joaquim Majó Fernández, & Rafael Esteban. (2007). De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection. International Urology and Nephrology. 40(2). 539–541. 9 indexed citations
9.
Arbós, M.A., J. Leiro, Maite Quiles, et al.. (2000). Early effects of exogenous arginine after the implantation of prosthetic material into the rat abdominal wall. Life Sciences. 67(20). 2493–2512. 21 indexed citations
10.
Rovira, Ana, et al.. (1989). [Computerized tomography findings in annular pancreas in an adult].. PubMed. 75(6 Pt 2). 695–7. 1 indexed citations
11.
Romero‐Salguero, Francisco J., et al.. (1984). Cerebral Computed Tomography in Maple Syrup Urine Disease. Journal of Computer Assisted Tomography. 8(3). 410–411. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026